BioCentury
ARTICLE | Clinical News

Oral solithromycin: Phase III data

January 12, 2015 8:00 AM UTC

Cempra is evaluating IV solithromycin in the Phase III Solitaire-IV trial to treat CABP. The company plans to include pooled data from both trials in an NDA to FDA under proposed FDA CABP guidance, wh...